and the tDepartment of Microbiology, Cliniques Universitaires St Luc, B-1200 Brussels, Belgium suMMARY Routine culture and cold enrichment were compared in a prospective study on the isolation of Yersinia enterocolitica from patients with intestinal disease. Healthy controls were examined with the cold enrichment method only.
(9.1 %), and more often than Cantpylobacterjejuni (18 %) and Shigella (0.1 %).
Yersinia enterocolitica was described more than forty years ago,' but it is only in the last decade that this organism has emerged as a frequent pathogen. In many European countries, particularly in Belgium and Scandinavia, Y enterocolitica is second only to Salmonella as an aetiological agent of bacterial gastroenteritis. In these and most other countries, among the great number of known serotypes, only types 0:3 and 0:9 are regularly associated with disease in man.
Even now, Y enterocolitica is rare or unknown in many parts of the world, particularly in developing countries; this could be explained, perhaps, by the lack of detection facilities and trained personnel. It is more difficult, however, to explain its apparent rarity in highly developed countries where technical skill and awareness of the organism should promote its isolation. This is all the more puzzling for countries such as France and the USA, which have a common border respectively with Belgium and Canada, two countries where Y enterocolitica is frequently isolated. Such differences have often been accounted for by the delicate and requires special media and low incubation temperatures. There have been enthusiastic reports on the use of cold enrichment in buffer or broth, a procedure which is unpractical for clinical diagnosis, since the recovery of Yersinia may then require several weeks.
In a recent study we have demonstrated2 that the addition of cold enrichment to routine stool cultures resulted in an increase in the recovery of Y enterocolitica from patients' stools. However, all the strains that were exclusively grown from cold enrichment, belonged to serotypes other than the common human serotypes 0:3 and 0:9. We presented evidence that these types were not pathogenic and that cold enrichment was of no value in the diagnosis of patients with acute enteritis. At tDifference between serotypes 0:3 and 0:9 and other serotypes highly significant when comparing "specific" against non-specific or asymptomatic presentation (p < 0 01). Table 1 shows the number and percentage of pathogenic bacteria isolated from patient specimens. The number of patients was somewhat lower than the number of isolates due to the reisolation of the same Yersinia strain in 12 convalescent patients. In three patients, two different serotypes of Y enterocolitica were isolated from the same stool specimen. Overall, 278 bacterial pathogens were isolated from 1635 stool specimens, representing 17 pathogens per 100 stools, excluding enteropathogenic Escherichia coli. Appendixes were positive less frequently: 15 pathogens in 206 specimens (7-3 %).
The clinical presentation of the infection, according to the serotypes of Yersinia, appears in Table 2 . There were 82 patients with one or more cultures positive for Yersinia. The great majority (81 1 %) of serotypes 0:3 and 0:9 strains were associated with enteritis or an appendicular pain syndrome, and the reverse was true for strains of other serotypes: 70 3 % came from asymptomatic contacts or from subjects with non-specific gastrointestinal complaints. This difference was highly significant (p = <0-01). Table 3 compares the number and percentages of isolates that were recovered respectively by the combination of routine culture media and by cold enrichment in buffer. It appears that 80-6 % of 0:3 and 0:9 isolates were recovered from the routine media, against none of the other serotypes. The latter were exclusively recovered from cold enrichment. Table 4 shows the number and percentages of Yersinia isolates from the 555 healthy controls. While serotype 0:3 and 0:9 comprised 69 % of isolates from patients, their proportion was only 13-6% of strains isolated from healthy subjects.
All the 22 carriers of Yersinia in the control group were available for interview and medical examination. Two school children with serotype 0:3 and serotype 0:9 positive stool admitted to having a mild diarrhoea, and an adult with the latter serotype complained of polyarthritis and abdominal discomfort. In contrast, nothing abnormal was noted in the 19 carriers of other serotypes, with the exception of vague non-specific digestive complaints in one of them. (Table 5) . Serotypes and biotypes of the Yersinia isolates from stools of patients and controls are listed in Table 6 . 
The high prevalence of Yersinia enterocolitica in stools of patients with gastroenteritis and various digestive complaints has been confirmed. Nearly 6 % were positive, a figure which is higher than previous isolation rates recorded in Belgium and in other countries2 and which comes close to the isolation rate of Salmonella, the most frequent bacterial pathogen in stools. However, the increase in isolation rates over earlier figures is partly due to the addition of a large number of non 0:3-non 0:9 serotypes, which were exclusively recovered by cold enrichment.
There is growing evidence, at least in Belgium, that serotypes, other than the common recognised "human" serotypes 0:3 and 0:9, have no pathogenic potential. A striking difference between the clinical presentation of the "human" and the other serotypes is shown in Table 2 . While the former are chiefly isolated from patients with gastroenteritis and abdominal pain syndromes, the latter are significantly more often found in patients with non-specific pathology.
As shown in Table 3 , more than 80% of the recognised human pathogenic serotype 0:3 and 0:9 strains are recovered with a routine scheme for stool culture comprising MacConkey and SS agar as direct plating media, and selenite and modified Rappaport broth as enrichment. No single isolate was contributed by the inclusion of MacConkey agar and only one was recovered exclusively from selenite broth. The SS + modified Rappaport broth combination therefore seems to satisfy the needs of the diagnostic bacteriologist, as we demonstrated earlier.2 The 19-4% increase of 0:3 and 0:9 isolates by cold enrichment may justify the routine adoption of this technique. However, a closer look at the 13 strains that were exclusively grown after cold enrichment, reveals that seven were second isolations from convalescent patients, two were from healthy contacts, and one from a patient with polyarthritis. Only three patients with acute Yersinia infection would have been missed by the exclusive use of our routine stool culture technique.
Our findings are in keeping with the conclusions of other investigators3 8 that the value of cold enrichment is limited to the detection of Yersinia in convalescent patients, in healthy contacts and in patients with late manifestations of the infection.
As could be expected, the isolation rate of serotypes 0:3 and 0:9 was eight times higher among patients than in healthy controls, even when only the results of cold enrichment were compared (3-9 % against 0 5%; p < 0-01). This difference would still have been greater if a few "patients" had not been included in the control group.
In contrast, the non 0:3-non 0:9 serotypes were nearly twice as frequent in the stools of controls than in patient stools (3 4% against 1 8%) although the difference was not statistically significant (p > 0 05). None of the patients or healthy controls harbouring serotypes other than 0:3 and 0:9 had agglutinins against the homologous strain, while the presence of a significant agglutination titre was the rule in patients infected by strains belonging to serotypes 0:3 and 0:9. This supports the lack of pathogenicity of the "other" serotypes.
As shown in Table 6 , the "other" Yersinia show a large number of 0-factors, rather evenly distributed between patients and controls. Most of these strains are of biotype 1, but some of them fit into new biochemical groups, mainly known as being from environmental origin. The names Y intermedia and Y frederiksenii were suggested9 for rhamnose and melibiose, and rhamnose fermenting strains respectively. Biotype 3A was recently described.'0 For the sucrose-negative strains the specific name Ykristensenii (H Bercovier, personal communication, 1980) has been suggested. It is not surprising that these environmental strains are occasionally found in human stools. It must be emphasised that cold enrichment, though somewhat useless for clinical diagnosis, has proved to be a valuable method for the identification of carriers, for the follow-up of convalescents and for ecological studies of environmental samples and food. However, the presence of serotypes other than 0:3 and 0:9 serotypes and aberrant biotypes in food and the environment should not be interpreted as being of public health importance.
